GV (nerve agent): Difference between revisions
Appearance
Content deleted Content added
Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.8.6 |
added Category:Phosphorus-nitrogen compounds using HotCat |
||
(3 intermediate revisions by 2 users not shown) | |||
Line 3: | Line 3: | ||
| verifiedrevid = 470455587 |
| verifiedrevid = 470455587 |
||
| Name = GV |
| Name = GV |
||
| OtherNames = EA-5365 |
|||
| ImageFile1 = GV-2D-skeletal.png |
| ImageFile1 = GV-2D-skeletal.png |
||
| ImageName1 = Skeletal formula of GV |
| ImageName1 = Skeletal formula of GV |
||
Line 31: | Line 32: | ||
}} |
}} |
||
'''GV''' ([[IUPAC]] name: '''2-(Dimethylamino)ethyl ''N'',''N''-dimethylphosphoramidofluoridate''') is an [[organophosphate]] [[nerve agent]]. GV is a part of a new series of nerve agents with properties similar to |
'''GV''' ([[IUPAC]] name: '''2-(Dimethylamino)ethyl ''N'',''N''-dimethylphosphoramidofluoridate'''), also known as '''EA-5365''', is an [[organophosphate]] [[nerve agent]]. GV is a part of a new series of nerve agents with properties similar to the "G-series" and "V-series". It is a potent [[acetylcholinesterase]] inhibitor with properties similar to other nerve agents, being a highly poisonous vapour. Treatment for poisoning with GV involves drugs such as [[atropine]], [[benactyzine]], [[obidoxime]], and [[HI-6]].<ref>{{ cite journal | vauthors = Fusek J, Bajgar J | title = Treatment of intoxication with GV compound in laboratory rats | journal = Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove | year = 1994 | volume = 37 | issue = 2 | pages = 57–62 | pmid = 7784799 }}</ref><ref>{{ cite journal | vauthors = Kassa J, Bajgar J | title = Therapeutic efficacy of obidoxime or HI-6 with atropine against intoxication with some nerve agents in mice | journal = Acta Medica (Hradec Kralove) | year = 1996 | volume = 39 | issue = 1 | pages = 27–30 | pmid = 9106387 }}</ref> |
||
==See also== |
==See also== |
||
Line 54: | Line 55: | ||
[[Category:Phosphorofluoridates]] |
[[Category:Phosphorofluoridates]] |
||
[[Category:G-series nerve agents]] |
[[Category:G-series nerve agents]] |
||
[[Category:Phosphorus-nitrogen compounds]] |
|||
{{Organic-compound-stub}} |
{{Organic-compound-stub}} |
Latest revision as of 11:57, 14 November 2024
Names | |
---|---|
IUPAC name
2-(Dimethylamino)ethyl N,N-dimethylphosphoramidofluoridate
| |
Other names
EA-5365
| |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C6H16FN2O2P | |
Molar mass | 198.176 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
GV (IUPAC name: 2-(Dimethylamino)ethyl N,N-dimethylphosphoramidofluoridate), also known as EA-5365, is an organophosphate nerve agent. GV is a part of a new series of nerve agents with properties similar to the "G-series" and "V-series". It is a potent acetylcholinesterase inhibitor with properties similar to other nerve agents, being a highly poisonous vapour. Treatment for poisoning with GV involves drugs such as atropine, benactyzine, obidoxime, and HI-6.[1][2]
See also
[edit]References
[edit]- ^ Fusek J, Bajgar J (1994). "Treatment of intoxication with GV compound in laboratory rats". Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove. 37 (2): 57–62. PMID 7784799.
- ^ Kassa J, Bajgar J (1996). "Therapeutic efficacy of obidoxime or HI-6 with atropine against intoxication with some nerve agents in mice". Acta Medica (Hradec Kralove). 39 (1): 27–30. PMID 9106387.
External links
[edit]Wikimedia Commons has media related to GV nerve agent.
- Harvey SP, Cheng TC (2002). "Identification, Purification, and Partial Characterization of the GV-Degrading Enzyme from ATCC # 29660 Alteromonas undina". Aberdeen Proving Ground: Edgewood. OCLC 74239874. Report ECBC-TR-229. Archived from the original (pdf) on 2013-09-09. Retrieved 2013-09-09.
- Bajgar J (1998). "Some Toxic Chemicals as Potential Chemical Warfare Agents - The Threat for the Future?". ASA Newsletter. 1998 (6).